These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 11916315)

  • 1. Outcome of tyrosinaemia type III.
    Ellaway CJ; Holme E; Standing S; Preece MA; Green A; Ploechl E; Ugarte M; Trefz FK; Leonard JV
    J Inherit Metab Dis; 2001 Dec; 24(8):824-32. PubMed ID: 11916315
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tyrosinemia Type III detected via neonatal screening: management and outcome.
    Heylen E; Scherer G; Vincent MF; Marie S; Fischer J; Nassogne MC
    Mol Genet Metab; 2012 Nov; 107(3):605-7. PubMed ID: 23036342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the 4-hydroxyphenylpyruvate dioxygenase gene (HPD) in patients with tyrosinemia type III.
    Rüetschi U; Cerone R; Pérez-Cerda C; Schiaffino MC; Standing S; Ugarte M; Holme E
    Hum Genet; 2000 Jun; 106(6):654-62. PubMed ID: 10942115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predicting tyrosinaemia: a mathematical model of 4-hydroxyphenylpyruvate dioxygenase inhibition by nitisinone in rats.
    Ward JP; Dunster JL; Derks G; Mistry P; Salazar JD
    Math Med Biol; 2017 Sep; 34(3):335-390. PubMed ID: 27305933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term safety and outcomes in hereditary tyrosinaemia type 1 with nitisinone treatment: a 15-year non-interventional, multicentre study.
    Spiekerkoetter U; Couce ML; Das AM; de Laet C; Dionisi-Vici C; Lund AM; Schiff M; Spada M; Sparve E; Szamosi J; Vara R; Rudebeck M
    Lancet Diabetes Endocrinol; 2021 Jul; 9(7):427-435. PubMed ID: 34023005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatorenal Tyrosinaemia: Impact of a Simplified Diet on Metabolic Control and Clinical Outcome.
    Bärhold F; Meyer U; Neugebauer AK; Thimm EM; Lier D; Rosenbaum-Fabian S; Och U; Fekete A; Möslinger D; Rohde C; Beblo S; Hochuli M; Bogovic N; Korpel V; Dahl SV; Mayorandan S; Fischer A; Freisinger P; Dokoupil K; Heddrich-Ellerbrok M; Jörg-Streller M; van Teeffelen-Heithoff A; Lahl J; Das AM
    Nutrients; 2020 Dec; 13(1):. PubMed ID: 33396520
    [No Abstract]   [Full Text] [Related]  

  • 7. Autoimmune thyroiditis in a case of tyrosinaemia type III.
    D'Eufemia P; Giardini O; Cantani A; Martino F; Finocchiaro R
    J Inherit Metab Dis; 1992; 15(6):861-2. PubMed ID: 1293381
    [No Abstract]   [Full Text] [Related]  

  • 8. Tyrosinaemia type III: immunochemical studies on 4-hydroxyphenylpyruvic acid dioxygenase and molecular cloning of cDNA for the enzyme.
    Endo F; Awata H; Tanoue A; Eda Y; Matsuda I
    J Inherit Metab Dis; 1991; 14(5):783-6. PubMed ID: 1779624
    [No Abstract]   [Full Text] [Related]  

  • 9. Putative genetic deficiency of 4-hydroxyphenylpyruvic acid dioxygenase in mice: a murine model for hereditary tyrosinaemia type III.
    Endo F; Katoh H; Matsuda I
    J Inherit Metab Dis; 1990; 13(5):780-2. PubMed ID: 2246865
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunological abnormalities in a patient with tyrosinaemia type III.
    D'Eufemia PD; Finocchiaro R; Celli M; Viozzi L; Giardini O
    J Inherit Metab Dis; 1995; 18(3):355-6. PubMed ID: 7474904
    [No Abstract]   [Full Text] [Related]  

  • 11. Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia.
    Weigel JF; Janzen N; Pfäffle RW; Thiery J; Kiess W; Ceglarek U
    J Inherit Metab Dis; 2007 Aug; 30(4):610. PubMed ID: 17694358
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recommendations for the management of tyrosinaemia type 1.
    de Laet C; Dionisi-Vici C; Leonard JV; McKiernan P; Mitchell G; Monti L; de Baulny HO; Pintos-Morell G; Spiekerkötter U
    Orphanet J Rare Dis; 2013 Jan; 8():8. PubMed ID: 23311542
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tyrosinaemia type II with diffuse plantar keratoderma and self-mutilation.
    Madan V; Gupta U
    Clin Exp Dermatol; 2006 Jan; 31(1):54-6. PubMed ID: 16309482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosinemia type III: diagnosis and ten-year follow-up.
    Cerone R; Holme E; Schiaffino MC; Caruso U; Maritano L; Romano C
    Acta Paediatr; 1997 Sep; 86(9):1013-5. PubMed ID: 9343288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosinaemia type II: an easily diagnosed metabolic disorder with a rewarding therapeutic response.
    al-Essa MA; Rashed MS; Ozand PT
    East Mediterr Health J; 1999 Nov; 5(6):1204-7. PubMed ID: 11924112
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oculocutaneous tyrosinaemia or tyrosinaemia type 2: a case report.
    Valikhani M; Akhyani M; Jafari AK; Barzegari M; Toosi S
    J Eur Acad Dermatol Venereol; 2006 May; 20(5):591-4. PubMed ID: 16684290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural Protein Tolerance and Metabolic Control in Patients with Hereditary Tyrosinaemia Type 1.
    Yilmaz O; Daly A; Pinto A; Ashmore C; Evans S; Gupte G; Santra S; Preece MA; Mckiernan P; Kitchen S; Ayhan NY; MacDonald A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32325917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benign tyrosinaemia: an 18-year follow-up.
    Stoppoloni G; Santinelli R; Prisco F; Canino G; Iafusco D; Di Palma F
    J Inherit Metab Dis; 1995; 18(5):641-2. PubMed ID: 8598649
    [No Abstract]   [Full Text] [Related]  

  • 19. Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase.
    Lindstedt S; Holme E; Lock EA; Hjalmarson O; Strandvik B
    Lancet; 1992 Oct; 340(8823):813-7. PubMed ID: 1383656
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant analysis of HPD genes from two families showing elevated tyrosine upon newborn screening by tandem mass spectrometry (MS/MS).
    Zhao D; Tian Y; Li X; Ni M; Zhu X; Jia L
    J Pediatr Endocrinol Metab; 2020 Apr; 33(4):563-567. PubMed ID: 32109208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.